Roche Holding Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AAPL | Apple | Outperform |
16
|
$189.87 | $200.65 | 6.72% | 12 | $2.93T |
| LLY | Eli Lilly and | Outperform |
16
|
$770.00 | $636.99 | 13.96% | 9 | $693.31B |
| AVGO | Broadcom | Outperform |
8
|
$1.40k | $1.21k | 11.80% | 11 | $646.61B |
| ABBV | AbbVie | Outperform |
9
|
$166.42 | $178.42 | 9.66% | 11 | $293.88B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | £165.99 | 34.64% | 16 | £187.73B |
| DHR | Danaher | Outperform |
10
|
$265.80 | $260.33 | 2.49% | 4 | $196.87B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | $118.92 | 21.53% | 7 | $181.08B |
| GE | General Electric | Buy |
8
|
$159.89 | $144.00 | 12.59% | 3 | $175.02B |
| AMGN | Amgen | Outperform |
4
|
$312.47 | $303.65 | 2.41% | 8 | $167.62B |
| BSX | Boston Scientific | Buy |
11
|
$74.65 | $70.14 | 9.85% | 6 | $109.75B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | $58.15 | 22.64% | 10 | $89.25B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | $87.82 | 18.13% | 14 | $84.36B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$236.30 | $284.47 | 17.44% | 8 | $68.29B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.53k | ¥5.24k | 7.58% | 0 | ¥10.60T |
| MMM | 3M | Hold |
10
|
$105.26 | $109.39 | -1.67% | 3 | $58.25B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.01k | ¥4.92k | 21.83% | 0 | ¥8.24T |
| DXCM | DexCom Inc | Buy |
12
|
$131.36 | $125.98 | 15.83% | 2 | $52.24B |
| A | Agilent Technologies | Outperform |
10
|
$154.23 | $138.82 | -2.09% | 10 | $45.20B |
| ALC | Alcon | Outperform |
8
|
CHF80.08 | CHF90.64 | 20.97% | 3 | CHF39.59B |
| CTVA | Corteva | Outperform |
12
|
$56.45 | $61.72 | 15.15% | 1 | $39.34B |
| BIIB | Biogen | Outperform |
10
|
$230.57 | $299.62 | 25.12% | 13 | $33.57B |
| DD | DuPont de Nemours | Outperform |
17
|
$79.91 | $75.38 | 3.87% | 14 | $33.41B |
| BAYN | Bayer | Hold |
5
|
28.58€ | 45.15€ | 4.97% | 4 | 28.08€B |
| 7751 | Canon | Hold |
18
|
¥4.28k | ¥3.74k | -11.24% | 0 | ¥3.69T |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.04k | kr2.71k | 29.35% | 14 | kr131.83B |
| BGNE | BeiGene | Buy |
6
|
$172.85 | $285.19 | 55.63% | 2 | $18.08B |
| CE | Celanese | Hold |
13
|
$157.34 | $148.23 | 6.14% | 18 | $17.18B |
| BIM | bioMérieux | Outperform |
18
|
95.90€ | 105.55€ | 19.92% | 1 | 11.73€B |
| 4523 | Eisai | Outperform |
18
|
¥6.78k | ¥9.58k | 23.91% | 0 | ¥1.97T |
| TECH | Bio-Techne Corp | Buy |
16
|
$83.81 | $100.78 | 0.23% | 2 | $12.55B |
| FME | Fresenius Medical Care AG & Co... | Hold |
18
|
40.46€ | 41.13€ | -3.61% | 12 | 11.38€B |
| ERF | Eurofins Scientific | Hold |
18
|
58.26€ | 0.00€ | 2.99% | 5 | 11.05€B |
| BRKR | Bruker | Outperform |
16
|
$75.07 | $73.64 | 14.56% | 1 | $11.08B |
| EXAS | Exact Sciences | Buy |
8
|
$50.38 | $90.32 | 68.72% | 7 | $9.96B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.08 | £65.12 | 8.33% | 6 | £6.81B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$293.85 | $536.80 | 40.89% | 1 | $7.92B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$104.96 | $85.71 | 14.33% | 5 | $6.78B |
| EXEL | Exelixis | Outperform |
16
|
$20.91 | $26.44 | 29.12% | 5 | $6.34B |
| GETI B | Getinge AB | Outperform |
18
|
kr185.50 | kr226.10 | 21.83% | 3 | kr63.33B |
| DIA | DiaSorin S.p.A. | Hold |
18
|
102.05€ | 102.04€ | -1.08% | 1 | 5.26€B |
| CLN | Clariant | Outperform |
18
|
CHF14.42 | CHF16.11 | 10.96% | 6 | CHF4.67B |
| BIOCON | Biocon | Hold |
14
|
Rp305.85 | Rp270.86 | -6.82% | 14 | Rp365.06B |
| ALKS | Alkermes | Outperform |
10
|
$24.15 | $33.27 | 32.51% | 3 | $4.11B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$12.38 | HK$3.96 | -68.98% | 0 | HK$26.30B |
| 002773 | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥22.71 | ¥24.00 | -100.00% | 1 | ¥21.63B |
| EKTA B | Elekta AB (publ) | Hold |
18
|
kr82.25 | kr83.00 | -5.17% | 3 | kr30.26B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.77 | $9.50 | 40.32% | 5 | $2.55B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.46 | $23.40 | 2.12% | 4 | $2.19B |
| 300676 | BGI Genomics | - |
17
|
¥41.30 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$6.28 | $14.09 | 75.16% | 2 | $1.09B |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$3.61 | $8.67 | 52.35% | 2 | $515.79M |
| DHG | DHG Pharmaceutical Joint Stock | Hold |
18
|
115.60k | 125.44k | 0.86% | 0 | 14.92T |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.12 | $10.86 | 277.36% | 3 | $255.37M |
| ALIM | Alimera Sciences | Buy |
9
|
$3.20 | $7.00 | 150.00% | 3 | $171.72M |
| DBD | Binh Dinh Pharmaceutical and M... | Outperform |
15
|
₫52.70k | ₫62.90k | 10.06% | 1 | ₫3.97T |
| DCL | Cuu Long Pharmaceutical Joint ... | - |
12
|
₫30.10k | ₫0.00 | -100.00% | 0 | ₫1.97T |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£28.31 | £0.00 | -100.00% | 0 | £3.30B |
| DMC | Domesco Medical Import - Expor... | - |
0
|
₫56.20k | ₫0.00 | -100.00% | 0 | ₫1.74T |
| BNGO | Bionano Genomics | Outperform |
6
|
$1.14 | $12.33 | 426.32% | 2 | $65.69M |
| AGL | ANGLE | Buy |
8
|
£0.21 | £0.97 | 228.57% | 0 | £46.23M |
| DRIO | DarioHealth | Buy |
6
|
$1.90 | $4.70 | 163.16% | 1 | $54.88M |
| BCART | Biocartis Group NV | - |
7
|
0.29€ | 1.10€ | -100.00% | 0 | 27.24€M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.88 | $5.00 | -100.00% | 1 | $19.07M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.60 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| DBT | Ben Tre Pharmaceutical Joint S... | - |
8
|
₫12.45k | ₫0.00 | -100.00% | 0 | ₫207.33B |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $0.53M |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |